chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After pt received vaccine, pt became diaphoretic, complained of headache and was pale. Pt sat down in chair and feet propped up. Pt given juice and crackers. Pt laid down for the following 30 minuets to observe. pt discharged with mother with NAD, equal and unlabored breaths, warm, dry and pink.
Low Grade fever, body aches, mild headache for 3 days, Tylenol for fever
Large localized swelling, urticaria (generalized) within two or three minutes of vaccine. 1 tsp children's benedryl given at the time, patient was monitored for twenty minutes.  Symptoms resolved.  Symptoms reappeared one week later after patient ate eggs for the first time, including a large swelling at the vaccine site.
Began having nerve pain in right leg, then rashes began to appear following the same area as the nerve pain. Was prescribed Acyclovir 800mg 5 times per day, and Gabapentin and Percocet for pain.
2/5/21 -Rapid heart rate, heart palpitations lasting from 7pm til 10 am next morning 2/21/21- Another bout of heart palpitations lasting from 7 pm til about 10 am next morning 2/22/21- Urgent care visit. Blood drawn and EKG. No heart attack indicated. Scheduled stress test with echocardiogram and heart monitor 2/26/21 -2nd Moderna vaccine administrered 3/12/21 - Heart palpitations and rapid heart rate lasting 7 pm til mid morning 3/13/21- Urgent Care visit,  3/16/21 - Cardioloty lab for stress test, echocaridogram and fitted for Zio heart monitor 3/25/21 Psychotherapy for anxiety, depression, fear of going out despite being vaccinated 4/1/21 - Urgent care for head cold, cold sore on lip and nose, scratchy throuat mild earache. Negative tests for both STREP and Covid. 4/6/21 - Urgent Care. Head cold moved to chest, dry cought, 99.1 temp, extreme fatigue and lethargy, emotional panic, depression. Negative covid test. 4/7/21 Psychotherapy for depression and anxiety 4/12/21- First sign of Granuloma Anulare in more than 2 years 4/17/21-ER visit due to heart palpitations, tightness in jaw line, shortness of breath starting at 7 pm.ELG abnormal, 140 pulse, elevated blood pressure. Monitored til stable. Started blood thinner, Eliquis
Starting a week after my vaccine I have experienced uncontrolled itching head to toe off and on throughout the day and night. Once I begin itching hives and welts appear.  I have taken Claritin for 15 days with little to no relief. I was now prescribed cimetidine 200 mg and have taken for 4 days with no relief. I have no known allergies or a history of allergies. No new foods, soaps, detergents, no pets or exposure to plants or anything new. I had no major reactions to the 2 first moderna vaccines. Would like to know if this is a reaction others are getting and how and when will they subside
Pt received 1st dose Pfizer vaccine, completed 15 min observation and then started to feel intermittent dull chest pain. Pt denies SOB, non diaphoretic, denied any other health conditions, alert and oriented. Pt ambulated with steady gait. Medics called to assess Pt and was cleared to go home by EMTs after evaluation. Per EMTs Pt asymptomatic upon release.  Vitals 1505 BP 142/94 HR 69 RR 18 Temp 97.4F temporal O2 sat 98% on RA
Immediate onset of dizziness and fast heart rate.  (I did not report to Attendant because blamed it on feeling nervous.)  Dizziness subsided before leaving at 2:42p.  However, the fast heart rate was felt in evening hours before going to bed.   I felt fine next morning w/o any side effects..
Patient runs cross country. On Saturday, after a 2 mile run, her lips were blue, face was pale and she had difficulty breathing and recovering from her run. She began having a cough with light exertion that is still persistent. Tuesday, while in PE at school, she reported black dots in the corners of her vision that slowly got larger. She thought she was going to pass out. During this Tuesday episode, she reported vision changes including faces glowing bright white and flickers swirling around her vision.  We have kept her from running since Tuesday.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 20-MAY-2016, the patient received an improperly stored dose of ROTATEQ 2 ml, 10 unit dose tube, (lot # L000434, expiration 10-JUL-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/ Celsius) and the type of excursion (R/F) for each time were 168, 32 and R; 936, 34 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 17-OCT-2015 13:18, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 14.4 (5 hours 43 mins) and -2.6 (4 hours 19 mins) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
ON THE NIGHT OF 12/27/21 EMPLOYEE REPORTED RIGHT EYE SWELLING. EMPLOYEE STATED IT CAME UP AS A STY. TUESDAY SWELLING MOVED INTO NOSE AND ON WEDNESDAY IT WAS THE WHOLE RIGHT SIDE OF FACE. EMPLOYEE WENT TO CARE CENTER AND ER AND WAS TREATED.  EMPLOYEE RECEIVED A STERIOD SHOT IN THE ER AND WAS SENT HOME WITH AN ANTIBIOTIC EYE DROP, AZITHROMYCIN, CLINDAMYCIN, PEPCID AND WAS TO TAKE BENADRYL EVERY 4 HOURS. EMPLOYEE WAS DISCHARGED HOME.  ON THURSDAY IMPROVEMENT WAS NOTED. ON FRIDAY EMPLOYEES ENTIRE FACE WAS SWOLLEN. EMPLOYEE BACK TO ER AND EMPLOYEE RECEIVED IV PEPCID,  IV DECADRON, IV BENADRYL, AND WAS SENT HOME ON PREDISONE. ON SATURDAY IMPROVEMENT NOTED ON SUNDAY IMPROVEMENT NOTED. MONDAY 1/3/22 CONTINUES TO IMPROVE SL SWELLING IN NOSE IS NOTED.
VACCINE ADMINISTERED TO 17 YEAR OLD; OFF LABEL USE; This spontaneous report received from a pharmacist concerned a 17 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 211D21A, expiry: 11-APR-2022) dose was not reported, administered on 17-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 17-JAN-2022, the patient experienced vaccine administered to 17 year old, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered to 17 year old and off label use was not reported. This report was non-serious.
Within 1 to 2 minutes I quickly experienced shortness of breath, dizziness, overwhelming surge of heat to the point whereas the nurse said the white of my eyes turned red and I also felt nauseous. I felt like I was on fire. That evening I developed chills and a fever 102.7 taken at 2:00 A.M. Daytime temperature 9-26-2013 - 100 degrees, 9-27-2013 99 degrees. Remained feeling ill: weak, loss of appetite, very tired, for the next 2 days. Started feeling better 09-28-2013 - no temperature.
Localized reaction: severe pain in injected arm (to the point that arm was difficult to move), swelling, and erythema in the area surrounding the injection site.  Developed during evening of the day injection was given, continued through next day.   Treatment recommended: ice pack to affected area, acetaminophen, diphenhydramine.
Hep B was to be administered to patient, Men B was given instead at 9:23 am on 10/11/23. Patient is 8 days old.
head and body/aches; body/aches; fever; fatigue; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (head and body/aches), MYALGIA (body/aches), PYREXIA (fever) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 056M21A) for COVID-19 prophylaxis.     The patient was not diagnosed with/ tested positive for COVID-19.  Previously administered products included for Anxiety: Clonazepam since 21-Apr-2020; for Product used for unknown indication: Pfizer on 19-Feb-2021, Pfizer on 09-Mar-2021, Pfizer on 09-Oct-2021 and Flu vaccine on 01-Oct-2023. Past adverse reactions to the above products included No adverse event with Clonazepam, Flu vaccine, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Osteoporosis (just).    On 06-May-2022, the patient received fourth dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (head and body/aches), MYALGIA (body/aches), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, HEADACHE (head and body/aches), MYALGIA (body/aches), PYREXIA (fever) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  After each of her 6 COVID vaccinations, Patient have experienced head and body/aches, fever, and fatigue for approximately 36 hours.   Patient would like to know was it unusual to have fevers, a few aches and fatigue after having the Moderna Spikevax vaccine. She reported it packed more of a punch this time. This one hit her pretty hard. She was feeling well last night and then started feeling achy and had a fever but not high. She was really sick on Sunday night after she got the vaccine and typically has a fever. She was just concerned since it was 36 hours after the vaccine that she was still experiencing these reactions.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-743743 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-Oct-2023: Live follow up received contains reference number added. On 23-Oct-2023: Live Follow up received: Date of administration of suspect vaccine, historical vaccine, events has been added, and batch number updated, narrative was updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743743:Monovalent case
27-year-old female without significant past medical history who presents to the ER with 9/10 substernal chest pressure that awoke the patient from sleep at 4 AM and radiated to her left chest and neck. She has never had symptoms like this before. She reports nausea and one episode of vomiting with the pain around 430 AM. Did not feel better after. She called her mother crying due to the severity of the symptoms. She reports some shortness of breath but reports that taking a deep inspiration makes the discomfort better. She denies abdominal pain. She denies cough, rhinorrhea, fevers, or chills. She also denies arm pain, leg pain, back pain, numbness, weakness, tingling, dysuria, dysuria, constipation. No history of hyper-mobility. No trauma. He has frequent lose stool, but this is not new.     On arrival to the ED, her pain was a 7 or 8 out of 10 and had been constant since onset.  She reports that she had her second Moderna COVID vaccine on Tuesday 6/15/21 and wonders if it may be related. She had a breast reduction surgery in January 2021. No complications from that and no symptoms related to the surgery. No new medications. She got a GI cocktail with viscous lidocaine and Maalox in the ER and the pain has completely resolved.  She walks for exercise with her dog. No symptoms with that.
Initial report received from a healthcare professional on 10-Oct-2013. A 41-year-old female patient was given FLUZONE ID intradermal (on left) on 08-Oct-2013. Patient had injection site mosquito bite red, and stated was a painful day of vaccine. Also had golf ball sized next day, hot to the touch, red, slightly raised area. Event was improving by 10-Oct-2013. List of documents held by sender: none.
11 hours after injection I began to have chills and body ache, joint pain, muscle pain, slight headache, elevated temperature (max 100.0), dizziness, fatigue. All side effects subsided by 11/1 except fatigue. Fatigue subsided on 11/2.
5 hrs after shots headache, dizziness, 24 hrs after shots, headache, dizziness and ear ache, 48 hrs after shots headache, dizziness, ear ache and chest pain. 4 months later I have dizziness, chest discomfort, and shortness of breath.
Approximately 5-6 days after the booster shot, a dry rash appeared on my right and left inner arms (more rash on right than left). I have not sought medical treatment. Rash is not itchy, looks like psoriasis.  I have not previously experienced this type of rash. Both of my parents also have a similar rash following the Moderna booster.  Rash is on going but not severe (small areas on both arms) or bothersome.
Information has been received from a physician concerning an unknown number of patients who were vaccinated with varicella virus vaccine. The physician and his colleagues subsequently noticed a "25% failure or break through" among their patients that had been immunized. Additional info has been requested.
Red circle rash that developed a week after the shot. It's red, warm, itchy and makes my whole arm sore and tired.
DIVERTICULITIS; STROKE; BLEEDING IN THE BACK OF LEFT EYE; IRITIS; This spontaneous report received from a patient concerned a 71 year old female. The patient's weight was 245 pounds, and height was 66 inches. The patient was in perfect health prior to the vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, 1 total administered to right arm deltoid on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 20-MAY-2021, the patient experienced stroke and was hospitalized overnight and was discharged the following day (21-May-2021). Per patient stroke had caused her to lose sight of the left eye and her right eye had changed to 20-20 vision. On 05-JUL-2021, the patient was diagnosed with iritis. On 16-JUL-2021, the patient experienced diverticulitis and hospitalized for a day. On an unspecified date, the patient experienced bleeding in the back of left eye. Treatment medications (dates unspecified) included: acetylsalicylic acid (Aspirin), and atorvastatin calcium (Lipitor). The duration of hospitalization was 1 day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from diverticulitis, and the outcome of iritis, stroke and bleeding in the back of left eye was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210819912- Covid-19 vaccine ad26.cov2.s- Stroke, diverticulitis, bleeding in the back of left eye. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
shingles; chills; sweating; itching; tingling on right side of face; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced shingles, chills, sweating, pruritus and tingling. The patient was treated with vitamins nos (Vitamin). On an unknown date, the outcome of the shingles, chills, sweating, pruritus and tingling were unknown.   It was unknown if the reporter considered the shingles, chills, sweating, pruritus and tingling to be related to Flu vaccine.   Additional Information: GSK Receipt Date: 28-FEB-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter stated that he/she did not get any shots anymore. The patient got the flu shot years ago and had the chills sweating and did not trust anyone. The patient went to the doctor one day, he/she had tingling on his/her right side of his/her face and itching and he/she went to the doctor and he said he thought that he/she had shingles, every so often he/she got that and it went away.  The patient took vitamins that his/her son put him/her on. Additional Supportive Information: The follow up would not possible as no contact detail were available. The event shingles was a possible diagnosis so it was captured conservatively and the outcome of tingling ,shingles and pruritus was kept unknown because it was stated that every so often he/she got that and it went away.
fever for 4 days with breakthrough COVID on Sep2021; fever for 4 days with breakthrough COVID on Sep2021; fever for 4 days with breakthrough COVID on Sep2021; This is a spontaneous report from a contactable consumer. A 43-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered on 28Jan2021 as DOSE 2, SINGLE for COVID-19 immunization (age at vaccination 43 years) and received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered on 06Jan2021 as DOSE 1, SINGLE for COVID-19 immunization (age at vaccination 43 years). The patient medical history and concomitant medications was not reported. The patient did not have other vaccine in four weeks. The patient experienced fever for 4 days with breakthrough COVID on Sep2021 and vaccination failure. The patient underwent lab tests and procedures which included sars-cov-2 test reported result as positive on an unknown date. The outcome of the event was reported as recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected
Case number PHHY2012US051568 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with trivalent inactivated influenza vaccine (seasonal influenza vaccine, manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051559). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with birth defect, cystic adenomatoid malformation. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no usual patterns of pregnancy complications or fetal outcome were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
A report has been received from a Physician concerning an adult, male subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced headache. The patient recovered from the event of headache on an unspecified date. The report was considered to be non-serious.
Fever, muscle and joint aches, severe head ache,back ache, .Head ache lasted 4 days all other symptoms including fever lasted 3 days
Rash/bumps with redness on chest, abdomen, upper arm(biceps). Sights do not have ?itchy? sensation however does feel good when scratched. No course of action being taken via facility
24 hour after injection, chills, body ache and fever up to  100.7 F. Gone after another 24 hour. Extreme fatigue for at least 48 hour. Unable to perform routine chores for 48 hours.
patient administered acthib with expired sterile diluent with no reported adverse events; patient administered acthib with expired sterile diluent with no reported adverse events; Initial information received on 20-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who had patient administered acthib with expired sterile diluent with no reported adverse events after receiving vaccine hib (prp/t) vaccine [act-hib].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a  dose of suspect hib (prp/t) vaccine Powder and solvent for solution for injection, strength, dose, expiration date and lot number not reported via unknown route in unknown administration site for Immunization.  On an unknown date the patient developed a non-serious patient administered acthib with expired sterile diluent with no reported adverse events (expired product administered) and (product preparation error) ( (unknown latency).  Lab data was not reported.  Action taken was not applicable.  Outcome: Unknown for  both the events  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Approximately 2-3 hours after injection, nauseous, headache, sore arm, dizziness, lightheaded, and body aches that last for around 12-24 hours.
mental anxiety, confusion, restlessness, feeling directionless, in a fog, no drive, led to acute stress disorder
SEVERE MIGRAINE; RIGHT ARM WEAKNESS; LOSS OF TASTE; LOSS OF SMELL; This spontaneous report received from a patient concerned a 49 year old female. The patient's weight was 125 pounds, and height was 160 centimeters. The patient's concurrent conditions included migraine, history of concussion, post concussion syndrome, eye convergence inefficiency due to concussion, regelan and penicillin allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not had any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included gabapentin for severe migraine. On 17-APR-2021, the subject experienced loss of taste. On 17-APR-2021, the subject experienced loss of smell. On 22-APR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 23-APR-2021, the subject experienced severe migraine. On 23-APR-2021, the subject experienced right arm weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss of taste, loss of smell, severe migraine, and right arm weakness. This report was non-serious.; Sender's Comments: V0:Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.